Pages that link to "Q68246009"
Jump to navigation
Jump to search
The following pages link to Evaluation of efficacy of longer durations of therapy of fresh cases of kala-azar with sodium stibogluconate (Q68246009):
Displaying 8 items.
- Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective (Q28073426) (← links)
- Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India (Q28484459) (← links)
- Drug resistance in leishmaniasis (Q29616242) (← links)
- Miltefosine (Impavido): the first oral treatment against leishmaniasis (Q34265578) (← links)
- Therapeutic options for visceral leishmaniasis (Q37333942) (← links)
- The lost hope of elimination of Kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities? (Q37712177) (← links)
- Drug resistance in leishmaniasis (Q41271991) (← links)
- Clinicoepidemiological study of drug resistance in Indian kala-azar (Q41763228) (← links)